Target intelligence / Profile preview

Hemozoin inhibitor

Molecular classification: Other

Overview

Hemozoin inhibitors are a class of molecules that target the formation of hemozoin, a crystalline byproduct produced by malaria parasites (notably Plasmodium species) during the digestion of host hemoglobin inside red blood cells. The inhibition of hemozoin formation is a validated and essential antimalarial drug target because this process is critical for parasite survival and absent in humans, reducing the risk of off-target effects and resistance development.

Mechanism of action

Crystal growth inhibition; Heme complexation

Biological functions

Inhibition of hemozoin formationDetoxification of hemeAntiparasitic activity

Disease associations

Infection

Safety considerations

Resistance developmentImmune modulation

Interacting drugs

Chloroquine

4 more in the full profile.

Beyond the preview

Go deeper on Hemozoin inhibitor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemozoin inhibitor.

Explore the full profile